Clinical Innovations acquires French company MVF Disposables

Clinical Innovations, one of the world’s largest medical device companies focused on labor and delivery and neonatal intensive care, has acquired French company MVF Disposables.

The deal follows recent expansions by Clinical Innovations in Germany, Australia and China, supporting the company’s global growth strategy and strengthening its presence in the European market. A leading obstetrics company based in Nancy, MVF Disposables will operate as a wholly owned subsidiary of Clinical Innovations.

“Our growth is driven by our focus on improving outcomes for mothers, babies and physicians around the world,” said Ken Reali, president and CEO of Clinical Innovations. “Philippe Evrard, president of MVF, has built his medical device company into a first-rate organization. Adding it to the Clinical Innovations portfolio perfectly supports our goals and positions us to grow even more in the French and European markets. We look forward to welcoming the MVF Disposables team and working with them to continue our expansion.”

With industry-leading products such as the ebb® Complete Tamponade System, traxi® Panniculus Retractor and Kiwi® Vacuum-Assisted Delivery System, Clinical Innovations has a presence in more than 90 countries, including 85 percent of the hospitals in the U.S. and Western Europe. The company, based in Salt Lake City, has quickly grown its global footprint in recent years, expanding to new territories and strengthening its presence in established markets.

Health care expenditures in France are among the highest in Europe, at €240 billion per year. With a population of more than 67 million, 750,000 annual births and 500 maternity hospitals, France represents a significant opportunity for the company to expand its direct footprint in a major European market.

In 2017, Clinical Innovations acquired German company Brenner Medical GmbH. In June, it acquired Australian distributor JB Medical Supplies. And in July, it established CI Medical Instruments in China.

Clinical Innovations is owned by EQT, a leading investment firm with approximately EUR 50 billion in raised capital across 27 funds. Formed in 1993, Clinical Innovations is celebrating its quarter-century anniversary throughout 2018.